SexyMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: shoppers who want installment financing and can commit to a longer plan
SexyMD scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
SexyMD is a Nevada telehealth brand better known for sexual-health prescribing that now sells compounded GLP-1 injections alongside it. Both weight-loss products are priced by commitment length rather than by dose: the GLP-1 injection runs $269/month on the 4-week plan down to $199 on a 48-week plan, and the GLP-1/GIP injection $369 down to $299. Financing through Affirm, Klarna and Afterpay is offered at checkout.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to SexyMD
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
SexyMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- FDA status
- No FDA warning letter on record
How we scored SexyMD
Each dimension is scored algorithmically from SexyMD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.4/10At $199/mo, SexyMD runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
7.9/10SexyMD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience; 6 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-08-27).
Accessibility10%
8.1/10SexyMD treats patients in all 50 states.
Support10%
5.7/10SexyMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this SexyMD review
Last checked August 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with SexyMD
We walked SexyMD’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Open either product page — GLP-1 injection or GLP-1 + GIP injection — where all four plan lengths and their per-month prices are listed.
- 2A cookie consent banner appears first and must be dismissed before the page can be used.
- 3"Get Started" hands off to a separate intake host, intake.sexymd.com, carrying a session token in the URL.
- 4The walk was stopped at that hand-off rather than beginning the health questionnaire.
- Prices are shown before intake, but the headline "from $199 per month" is the 48-week tier — the month-to-month price is $269 and appears only in the plan table lower down.
- The 24- and 48-week plans state "Delivered every 12 weeks", so the per-month figure is an average across a quarterly shipment rather than a monthly charge.
- Both product pages carry an identical testimonial block, and a testimonial describing GLP-1 + GIP results appears on the plain GLP-1 page.
- Neither product page names semaglutide or tirzepatide; the molecules appear only in the terms and conditions.
- Intake is hosted on a different subdomain, so the funnel leaves the marketing site before any medical question is asked.
SexyMD customer support
- hello@sexymd.com
GLP-1 medications SexyMD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check SexyMD's current pricing and active discounts before you decide.
What we like
- All four commitment tiers are published on the product page with the per-month rate for each, before any intake.
- The terms name the pharmacy types used — U.S.-licensed 503A pharmacies and 503B outsourcing facilities — rather than leaving fulfillment vague.
- Installment financing is offered through Affirm, Klarna and Afterpay, which is unusual at this price point.
- The legal entity is stated plainly: SexyMD LLC, a Nevada limited liability company, with a published Las Vegas address.
- Terms confirm prescriptions may be filled with either FDA-approved brand medication or compounded product, depending on provider determination.
Watch-outs
- The advertised "from $199 per month" is the 48-week commitment; the month-to-month rate is $269, about 35% higher.
- Product pages never name the molecule — they say "GLP-1" and "GLP-1 + GIP", and only the terms mention semaglutide and tirzepatide.
- The same three customer testimonials run on both product pages, including a GLP-1/GIP testimonial displayed on the semaglutide page.
- "Loved by 800+ women" is repeated across the site with no source or methodology given.
- No individual compounding pharmacy is named, only the 503A/503B categories.
- Support is email-only at hello@sexymd.com — no phone number or published hours.
- State coverage is hedged: available in all 50 states but "some exclusions may apply" depending on pharmacy licensing.
Is SexyMD worth it? Our verdict
SexyMD positions itself around one thing: shoppers who want installment financing and can commit to a longer plan. It runs $199/month — a premium to the category, so the extras need to justify it. It treats patients in all 50 states, so access isn't a barrier.
SexyMD rounds out its offering with 503A and 503B and Financing Available.
How much SexyMD actually costs
- Compounded semaglutide — $269/month
- Compounded semaglutide — $249/month
- Compounded semaglutide — $229/month
- Compounded semaglutide — $199/month
- Compounded tirzepatide — $369/month
- Compounded tirzepatide — $349/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so SexyMD's standing rate sits at the premium end.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against SexyMD before you commit.
Medications: what SexyMD prescribes
SexyMD prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who SexyMD is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Sunlight will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
SexyMD treats patients in all 50 states, and dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
SexyMD costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
SexyMD scores highest on state availability and ease of access.
Ready to start with SexyMD?
Starting at $199/month. See current pricing and start your free consultation.
SexyMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this SexyMD review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See SexyMD's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.